Predictive value of recent quantiFERON conversion for tuberculosis disease in adolescents

American Journal of Respiratory and Critical Care Medicine

Volumn 186, Issue 10, 2012, Pages 1051-1056

  Machingaidze, Shingai ^a,b   Verver, Suzanne ^c,d   Mulenga, Humphrey ^a,b   Abrahams, Deborah Ann ^a,b   Hatherill, Mark ^a,b   Hanekom, Willem ^a,b   Hussey, Gregory D ^a,b   Mahomed, Hassan ^a,b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c KNCV TUBERCULOSIS FOUNDATION   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Adolescents; Predictive value; QuantiFERON conversion; Tuberculosis

Indexed keywords

GAMMA INTERFERON;

ADULT; ARTICLE; COHORT ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; QUANTIFERON TB GOLD IN-TUBE; TUBERCULIN TEST; TUBERCULOSIS;

ADOLESCENT; CHILD; HUMANS; INTERFERON-GAMMA RELEASE TESTS; LATENT TUBERCULOSIS; PREDICTIVE VALUE OF TESTS; TUBERCULIN TEST;

EID: 84869219134     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201206-1134OC     Document Type: Article

References (21)

1. Pai M, Zwerling A, Menzies D. Systematic review: T-cell based assay for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008;149:177-184.
2. vanZyl-Smit RN, Zwerling A, Dheda K, Pai M. Within-subject variability of interferon-γ assay results for tuberculosis and boosting effect of tuberculin skin testing: a systematic review. PLoS ONE 2009;4:e8517.
3. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007;146:340-354. (Pubitemid 351650594)
4. Pai M, Riley LW, Colford JM Jr. Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 2004;4:761-776.
5. Mazurek GH, Jereb J, Lobue P, Iademarco MF, Metchock B, Vernon A. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR 2005;54:49-55.
6. Canadian Tuberculosis Committee. Updated recommendations on interferon-gamma release assays for latent tuberculosis infection. An Advisory Committee Statement (ACS). Can Commun Dis Rep 2008; 34:1-13.
7. National Institute for Health and Clinical Excellence. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and its control. London, UK: National Institute for Clinical Excellence; 2006.
8. Denkinger C, Dheda K, Pai M. Guidelines on interferon-g release assays for tuberculosis infection: concordance, discordance or confusion? Clin Microbiol Infect 2011;17:806-814.
9. Pai M, O'Brien R. Serial testing for tuberculosis: can we make sense of T cell assay conversions and reversions? PLoS Med 2007;4:e208.
10. Pai M, Dheda K, Cunningham J, Scano F, O'Brien R. T-cell assays for the diagnosis of latent tuberculosis infection: moving the research agenda forward. Lancet Infect Dis 2007;7:428-438. (Pubitemid 46779096)
11. Pai M, Joshi R, Dogra S, Zwerling AA, Gajalakshmi D, Goswami K, Reddy MVR, Kalantri S, Hill PC, Menzies D, et al. T-cell assay conversions and reversions among household contacts of tuberculosis patients in rural India. Int J Tuberc Lung Dis 2009;13:84-92.
12. PaiM, Joshi R, Dogra S, Mendiratta DK, Narang P, Kalantri S, Reingold AL, Colford JM Jr, Riley LW, Menzies D. Serial testing of health care workers for tuberculosis using interferon-gamma assay. Am J Respir Crit Care Med 2006;174:349-355. (Pubitemid 44156616)
13. Hill PC, Brookes RH, Fox A, Jackson-Sillah D, Jeffries DJ, Lugos MD, Donkor SA, Adetifa IM, de Jong BC, Aiken AM, et al. Longitudinal assessment of an ELISPOT test for Mycobacterium tuberculosis infection. PLoS Med 2007;4:e192.
14. Menzies D. Interpretation of repeated tubeculin tests: boosting, conversion, and reversion. Am J Respir Crit Care Med 1999;159:15-21. (Pubitemid 29036497)
15. Menzies RI. Tuberculin skin testing. In: Reichman LB, Hershfield ES, editors. Tuberculosis: a comprehensive international approach. New York: Marcel Dekker; 2000. pp. 279-322.
16. English R. Annual health status report 2007/08. Boland-Overberg Region. Worcester, Western Cape, South Africa: Department of Health; 2010.
17. Groenewald P. Annual health status report 2006.Worcester,Western Cape, South Africa: Department of Health, Boland-Overberg Region; 2007.
18. Mahomed H, Hawkridge T, Verver S, Abrahams D, Geiter L, Hatherill M, Ehrlich R, Hanekom WA, Hussey GD. The tuberculin skin test versus QuantiFERON TB Gold in predicting tuberculosis disease in an adolescent cohort study in South Africa. PLoS ONE 2011;6:e17984.
19. Veerapathran A, Joshi R, Goswami K, Dogra S, Moodie EEM, Reddy MVR, Kalantri S, Schwartzman K, Behr MA, Menzies D, Pai M. T-cell assays for tuberculosis infection: deriving cut-offs for conversions using reproducibility data. Plos One 2008;3:e1850.
20. Harada N, Higuchi K, Sekiya Y, Rothel J, Kitoh T, Mori T. Basic characteristics of a novel diagnostic method (QuantiFERON TB-2G) for latent tuberculosis infection with the use of Mycobacterium tuberculosis-specific antigens, ESAT-6 and CFP-10]. Kekkaku 2004;79:725-735 (in Japanese). (Pubitemid 40364202)
21. Sutherland I. The evolution of clinical tuberculosis in adolescents. Tubercle 1966;47:308.